A thin-layer chromatography/densitometry method was developed and validated for the determination of oxycodone hydrochloride in oral solutions by using silica gel plates. A horizontal technique was used for development of the plates. The optimum composition for the mobile phase, which provided a suitable R f value of 0.6 for oxycodone, was propanol-acetic acid-water-25% ammonia-methanol (20 + 1 + 1 + 3 + 10). Detection was at 234 nm. Oxycodone hydrochloride was stable on the sorbent and was precisely and accurately measured in the range of 0.3-1.5 mg/band. O xycodone, (5")-4,5-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one, is a semisynthetic derivative of morphine (Figure 1 ). It is used as an analgesic agent and is almost as effective as morphine. Oxycodone hydrochloride salt dissolved in black currant syrup or in peppermint water is widely used in Finnish hospitals as an oral solution for the treatment of pain caused by cancer. The concentrations used vary from 1 to 5 mg/mL.
O xycodone, (5")-4,5-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one, is a semisynthetic derivative of morphine ( Figure 1 ). It is used as an analgesic agent and is almost as effective as morphine. Oxycodone hydrochloride salt dissolved in black currant syrup or in peppermint water is widely used in Finnish hospitals as an oral solution for the treatment of pain caused by cancer. The concentrations used vary from 1 to 5 mg/mL.
Oxycodone is susceptible to oxidation, especially in aqueous solutions where it is exposed to oxidative degradation (1, 2) . The N-oxide and an aldehyde have been identified after oxidation with hydrogen peroxide (1) and ozone (2) , respectively ( Figure 1) . However, the drug-decomposition kinetics of oral oxycodone solutions have not been studied, and this lack of information has been problematic in the hospitals. To study the stability of oxycodone in oral solutions, a reliable analytical method is needed. Liquid chromatography (LC) is now considered the most suitable technique to monitor the stability kinetics of drugs. However, the possibilities of modern thin-layer chromatography (TLC) must not be underestimated.
Methods for the determination of oxycodone hydrochloride in pharmaceutical preparations are based on spectrophotometry (3, 4) or colorimetry (5). Liquid (6-8) and gas chromatographic (9-11) methods have been applied to the determination of oxycodone hydrochloride in biological fluids in recent years. Available reports about the TLC of oxycodone describe methods in which conventional plates have been used for qualitative monitoring of oxycodone and its main metabolities (9, 12) . No quantitative densitometric TLC method has been reported. Accordingly, the aim of this work was to develop a TLC method for the determination of oxycodone hydrochloride in oral solutions without time-consuming pretreatment of the samples. The validation of an analytical method is an integral part of method development because its purpose is to demonstrate that the method is appropriate for the intended application. The validation of planar chromatographic methods has been addressed in some published papers (13) (14) (15) (16) (17) (18) (19) (20) (21) . The parameters examined in the present validation process were accuracy, precision, repeatability, linearity, selectivity/specificity, stability, and limit of quantitation. The work was mainly done according to the procedures of Ferenczi-Fodor et al. (15) because of the clarity of their presentation. In addition, the present paper describes preliminary studies to clarify if the developed method could be used for stability studies of oxycodone oral solutions as an alternative to LC.
Experimental

Reagents
Oxycodone hydrochloride was kindly supplied by Leiras Oy (Turku, Finland). The oral solutions of oxycodone hydrochloride were prepared according to the recipe of the Hospital Pharmacy, Turku University Central Hospital. The complete declarations for the oral solutions studied were as follows: oxycodone hydrochloride 3.0 mg, blackcurrant syrup 0.4 mL, and purified water 1.0 mL (oral solution 1); and oxycodone hydrochloride 3.0 mg, 10% solution of methyl p-hydroxybenzoate in ethanol 10 mg, and peppermint water 1.0 mL (oral solution 2). All other chemicals and reagents were analytical grade.
Apparatus
A Camag (Muttenz, Switzerland) TLC Scanner II controlled by the CATS 3.17 program was used to scan the plates at 234 nm (D 2 lamp). The scanning speed was 4.0 mm/s, and the monochromator bandwidth was set at 10 nm. The slit width and length were 0.2 and 2 mm, respectively. The scanner was operated in the absorption and reflection modes with sensitivity/span optimization. For integration, the data selection and filter factors were 1 and 3, respectively.
Chromatography
Silica gel high-performance TLC (HPTLC) plates, 10 × 20 cm (Merck Art. 5642, Darmstadt, Germany) were cleaned once by development in the mobile phase before use. Aliquots of 1-5 µL of the sample and the standard solutions (containing ca 0.3-1.5 µg oxycodone) were sprayed with a Linomat IV applicator (Camag) at a speed of 1 µL/15 s as 5 mm bands, 10 mm from the lower and vertical edges of the plate with 5 mm spaces between them. Propanol-acetic acid-water-25% ammonia-methanol (20 + 1 + 1 + 3 + 10, v/v/v/v/v) was used as the mobile phase. The plates were developed at room temperature in an unsaturated horizontal chamber (Camag), and then dried in a fume hood before they were scanned.
Validation of the TLC Method
In validation tests, the concentration of oxycodone hydrochloride was 0.3 mg/mL in both the sample and the standard solutions, if not stated otherwise. The solutions were obtained by diluting the stock solution containing oxycodone hydrochloride at 3 mg/mL with ethanol.
To validate the selectivity of the TLC method, the retention factor (R f ) of oxycodone, the tailing factor at 5% peak height (T 0.05 ), and the resolution (R s ) in the oral solutions (oxycodone versus excipients and oxycodone versus eluant front) were determined. The specificity of the method for determining oxycodone in the presence of excipients in oral solutions was studied by comparing the chromatograms of oral solutions with and without the active ingredient. The suitability of the method was also tested by chromatography of the oral solutions that had been refluxed for several hours.
To study the linearity of the method, 5 different volumes (1-5 µL) of the standard solution were applied as bands to the plate. The calibration curve was constructed by plotting peak height versus concentration of oxycodone, by using Michaelis-Menten regression 1.
The repeatability of the sample application was studied by applying the standard solution (0.3 mg/mL) in aliquots of 2 and 4 µL 6 times each. The repeatability of the total method was studied by preparing 6 different stock solutions, each of which was diluted to 6 parallel samples, which were applied to TLC plates in duplicate.
The accuracy of the method was evaluated by spiking solutions with 3 different amounts of oxycodone hydrochloride in duplicate (0.8, 1.0, and 1.2 µg oxycodone/band on the plate).
The limit of quantitation was determined by using oral solutions 1 and 2 with decreasing concentrations of oxycodone. The solutions were applied in triplicate to a TLC plate.
The stability of oxycodone in the sample solutions was studied by storing the solutions at room temperature for periods of 24, 4, 2, and 1 h, and 30 and 10 min before application.
Additionally, we investigated the stability of oxycodone on the sorbent before and after plate development. Duplicate applications of the solution containing oxycodone hydrochloride at 0.3 mg/mL was made on the same plate at 2 and 1 h, and at 45, 30, 15, and 2 min before development. The stability after development was studied by scanning the plates at 30 min and at 2, 4, and 24 h after development.
Results and Discussion
Among the many mobile phases tested, propanol-acetic acid-water-25% ammonia-methanol (20 + 1 + 1 + 3 + 10) proved to be the eluant of choice for the HPTLC assay. By cleaning the plates with mobile phase instead of with methanol, which is commonly used, a disturbing $-frontier was eliminated. The R f value of oxycodone was 0.6, and oxycodone was separated from both the excipients and the eluant front (Figure 2 ). In the case of oral solution 1, some of the components of black currant syrup either eluted with the solvent front or remained on the application band. Methyl-p-hydroxybenzoate, a stabilizing agent of oral solution 2, eluted with the solvent front.
Oxycodone had 2 absorption maxima, at 234 and 289 nm, when the spectrum was obtained in situ on the TLC plate. In the beginning, the measurements were made at both of the ab- Standard deviation of the calibration curves (fitted to the original calibration points) as a comparison of  different application techniques, analytical wavelengths, and integrations of the peak (height vs area 1 ≤8 a n = 6. b Each of 6 different stock solutions was diluted to 6 parallel samples, which were applied to TLC plates in duplicate.
sorption maxima, but the most reliable and repeatable results were obtained at 234 nm, which was selected for subsequent measurements. It was decided to use peak heights for quantification instead of peak areas; nevertheless, the difference between the results measured by peak height and peak area was small ( Table 1) . The tailing factor at 5% peak height (T 0.05 ) of the oxycodone peak and the resolution (R s ) in the oral solutions are presented in Table 2 . Because baseline resolution was achieved in every case and the tailing factor was acceptable, it was concluded that the excipients in the oral solutions and the eluant front do not interfere with the measurement of oxycodone. In addition, there was no peak with the R f value of 0.6 in the densitograms obtained for oral solutions 1 and 2 without the active ingredient, oxycodone. All the system suitability data comply with the acceptance criteria ( Table 2 ). The method is stability-indicating because there is no interfering peak in the densitogram of an oral solution refluxed for several hours (Figure 2) .
The calibration curve used in the quantitation of oxycodone hydrochloride was Michaelis-Menten regression 1 (y = [231.22x]/[1.816E + x]), which provided a better fit than did second-order polynomial regression. The calibration graph is forced through the origin, but it can be used when the results are not distorted (22) . Because of the better standard deviation (SD) of the calibration curve, different volumes of the standard solution were applied to the plate rather than identical volumes of different concentration diluted from the stock solution. A good agreement (SD = 0.4) between the standards and the Michaelis-Menten regression 1 was achieved in the range 0.3-1.5 µg ( Table 1) .
The repeatabilities of the application, the measurement of the peak height, and the whole method, (Table 3) show that in every case, the relative standard deviation (RSD) values are less than the limit values recommended in the literature (15) . The tests confirm that the method, including the equipment, is free of any large random errors.
The accuracy of the method was studied by measuring the solutions spiked with oxycodone hydrochloride. The measured values were compared with the known amounts. The RSD value for the method repeatability (3.6 and 3.1% for oral solutions 1 and 2, respectively, in Table 3 ) served as the acceptance criterion for the mean differences (15) . According to the results obtained (Table 4) , the method seemed to be good enough to monitor the concentration of oxycodone hydrochloride in the oral solutions studied. The limits of quantitation were approximately 100 ng for oral solution 1 and 60 ng for oral solution 2. The limit of detection was not measured because of the proposed use of the method.
Because oxycodone on a TLC plate is in contact not only with the plate surface but also with atmospheric gases, it can undergo oxidative degradation catalyzed by the free silanol groups on the sorbent. That is why the stability of the compound in sample solution (not <30 min), on the plate before development (not <15 min), and after development (≥1 h) was measured (Figure 3) . Oxycodone passed the acceptance criteria and proved to be stable enough both in sample solution and on the plate. The stability of oxycodone for ≥4 h on the sorbent is considered desirable, if the method will be used for a kinetic study of oxidative degradation of the compound in oral solutions.
It can be concluded that the developed TLC method proved to be reliable and suitable for determining oxycodone hydrochloride in oral solutions. It is a valuable technique that is an alternative to LC. The advantages of TLC over LC are that no sample pretreatment is needed, solvent consumption is lower, and analysis is faster because numerous samples can be measured on the same plate simultaneously. In addition, the TLC method is worthy of consideration for the determination of the kinetics of the oxidative degradation of oxycodone.
